Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 7
SNMMI: Machine-learning model predicts RPT dose
By
Will Morton
Dosimetry plays a central role in optimizing lutetium-177 (Lu-177) PSMA therapy, yet calculating it currently depends on post-therapy imaging.
May 30, 2026
Eye movement abnormalities flag brain health risk in ex-racing drivers
By
Kate Madden Yee
A case series of 12 male retired professional motorsport drivers showed a high prevalence of mild neurological abnormalities.
May 29, 2026
Health Canada clears latest Hermia molecular imaging update
By
AuntMinnie.com staff writers
The clearance allows for Hermia's clinical use across Canadian nuclear medicine and theranostics practices.
May 28, 2026
FDG-PET/CT predicts outcomes in patients with HCC
By
Will Morton
Elevated FDG uptake was consistently associated with poorer overall survival.
May 22, 2026
AuntMinnieEurope Molecular Imaging Insider
By
Claudia Tschabuschnig
This edition covers the latest in PET/CT quality assurance, theranostics pipeline updates, AI in nuclear medicine, and policy developments shaping the field across Europe.
May 6, 2026
How AI can help with PET/CT guideline deviations
By
Claudia Tschabuschnig
Researchers have found a gap between what international PET/CT guidelines recommend and what actually happens in clinical practice.
May 6, 2026
The EANM joins EMUC26 and pushes its policy agenda in Brussels
By
Claudia Tschabuschnig
Decisions shaping who gets access to theranostics in Europe have long been made mainly in the clinic. With EANM opening a Brussels office and joining EMUC26 as co-organizer, a full policy agenda arrives at the EU table.
May 5, 2026
Serac highlights study on 99mTc-maraciclatide for endometriosis care
By
AuntMinnie.com staff writers
Serac Healthcare is highlighting success from a study that evaluated the company's gamma-emitting radiotracer, 99mTc-maraciclatide.
April 30, 2026
Lu-177 PSMA-SPECT/CT predicts survival in mCRPC
By
Will Morton
Lu-177 PSMA-617 SPECT/CT total tumor volume complete response at six weeks associated with overall survival.
April 29, 2026
ChatGPT matches nuclear medicine experts on FDG-PET/CT scans
By
Will Morton
Models excelled on cases with well-defined metabolic patterns, such as in typical cases of Alzheimer's disease, yet were less accurate on complex cases.
April 24, 2026
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
By
AuntMinnie.com staff writers
TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.
April 22, 2026
PET links brain metabolism to survival in lung cancer patients
By
Will Morton
Low brain metabolic activity was associated with increased mortality in patients with advanced NSCLC.
April 9, 2026
Previous Page
Page 7 of 132
Next Page